Radar › Companies › Genomics · North Rhine Westphalia
Radar · Genomics in North Rhine Westphalia

Best Genomics Companies in North Rhine Westphalia, Germany

The 30 best Genomics companies in North Rhine Westphalia, Germany in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Singleron.

30companies tracked
$150.9Mdisclosed funding
0unicorns
13have raised
FLIAR INTELLIGENCE · GENOMICS × NORTH RHINE WESTPHALIA

Our analysis of 50 Genomics companies

$7.8b in tracked funding; 84% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.

50companies analysed
84%cloud-native stacks
2025funding peak (by rounds)
2unicorns
2016median founding year

Ranked: Best Genomics companies in North Rhine Westphalia

#CompanyLast roundDisclosed fundingEmployeesFoundedFounderTech stackPatents & IP focusRecent signals
1AgroProtect
Provider of agricultural consultation, data protection, and newsletter marketing services
———2010Dieter Peschen
Founder & CEO
———
2Carpegen
Developer of point-of-care diagnostics for the detection of pathogens
———2001Antje Roetger
Co-Founder & CEO
—20 patents
Patents concentrated in transport & manufacturing processes
—
3CoGAP
Provider of exercise and nutrition plans tailored to the individual's DNA
——72009Simon Keller
Managing Director
Cart FunctionalityWooCommerceWordPress+26——
4CreativeTherapeutics
Developer of therapies for treating cancer
———2009Hans Joachim Zeiler
Co-Founder & CEO
———
5DNA XY
Provider of DNA based paternity test
———2005Yildirim Bor
CEO
—2 patents
DNA sequencing methods and systems for biopolymer analysis
—
6FAIMA
Artificial Intelligence based medical assistance
———2018Zainetdinov Emil
CEO
———
7FASTGenomics
Provider of AI-based cell analysis and data management
———2016Stephan Huthmacher
CEO
———
8Liqomics
Provider of liquid biopsy cancer diagnostics using ctDNA
———2021Sven Borchmann
Founder & Managing Director
WordPressMySQLPHP+17——

Top 12 Genomics companies in North Rhine Westphalia

#1
Series B · Hagen, North Rhine Westphalia · founded 2018
$84.5Mraised
▾

Developer of single-cell multi-omics platform for clinical research and molecular diagnosis. It offers a product portfolio that includes instruments, microfluidic devices, reagents, software analysis, and database solutions that facilitate high-throughput single-cell analysis. It also, offers single cell sequencing services.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 19k LinkedIn followers — 11.8% of this cohort's audience
Funding rounds
  • Nov 2021Series B—
  • Dec 2020Series A$30M
  • Nov 2020Series A$10M
  • Sep 2020Series A$30M
Founders & team
Jing ZhouCo-FounderNan FangCo-Founder & CEOBruno MonschauManaging Director
Investors
Sherpa Venture Capital, Yuanhe Holdings, China Growth Capital, Frees Fund, CDH, LAV Asset Management
Tech stack
Apache Http ServerAutoptimizeBorlabs CookieCloudflareJqueryJquery Migrate
#2
Acquired · Cologne, North Rhine Westphalia · founded 2001 · 39 employees
$28.4Mraised
▾

Provider of glyco-optimized human cell lines and gene therapy vectors using proprietary cell expression system. The company has ELEVECTA technology for AAV manufacturing, CAP Go expression platform comprises a portfolio of glyco-optimized human suspension cell lines for tailor-made glycosylation of recombinant proteins. Provides the CAP GT expression platform, a scalable production system for gene therapy vectors. Also offers cell line development and protein expression services.

Funding rounds
  • Jul 2021Series E—
  • Apr 2019Series D—
  • Jul 2015Series C$4.9M
  • Oct 2012Series C$3.6M
Investors
NRW.Bank, Creathor Venture, Sparkasse, Midas Group, Peppermint VenturePartners, Danaher
Tech stack
WordpressMysqlPhpThe Seo FrameworkApache Http ServerJquery Migrate
#3
Funding Raised · Bergisch Gladbach, North Rhine Westphalia · founded 1989 · 585 employees
$12.7Mraised
▾

Develops tools and products for research and clinical application. The company offers biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation, cell culture, molecular analysis, clinical application, and imaging. They have expertise in immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 127k LinkedIn followers — 77.9% of this cohort's audience
Funding rounds
  • Mar 2021Grant (prize money)$304.4K
  • Jan 2021Grant (prize money)$821.7K
  • Jan 2020Grant (prize money)$539.1K
  • Jun 2019Grant (prize money)$283.1K
Founders & team
Stefan MiltenyiFounder & MDNorbert HentschelCFO / Managing DirectorBoris StoffelCEO
Investors
Europa, HHS
Tech stack
Amazon SesAmazon Web ServicesAngularApple Icloud MailCart FunctionalityCloudflare
#4
Deadpooled · Cologne, North Rhine Westphalia · founded 2010 · 40 employees
$18.5Mraised
▾

Ayoxxa Biosystems developed a technology platform for multiplexed protein analysis. The company's proprietary platform includes Lunaris BioChip that is used to identify and quantify proteins, including markers for cancer, allergies, cardiovascular or infectious diseases. It can be useful in biomedical research, pharmacological screening, and preclinical diagnostics development. The company also offers disease-specific detection kits such as 6-Plex Cytokine Kits to analyze biomarkers that are important in inflammation and in immune regulation.

Funding rounds
  • Jan 2017Grant (prize money)$21.9K
  • May 2015Grant (prize money)$681.5K
  • Dec 2014Series B$2.9M
  • Jun 2014Series B$12.3M
Investors
Europa, Wellington Partners Venture Capital, NRW.Bank, HTGF, Grazia Equity, BioMedPartners
Tech stack
CloudflareHttp/3
#5
Acquired · Cologne, North Rhine Westphalia · founded 2012 · 30 employees
$5.7Mraised
▾

Provider of pharmacogenomics tests for cancer. The company uses next-generation sequencing (NGS) for variant detection of two gene panels: NeoPlus, which uses FFPE and other solid tissue samples, and NEOLiquid for the detection of circulating cell-free DNA.

Funding rounds
  • Oct 2015Series D$5.7M
  • Mar 2015Series D—
#6
Funding Raised · Witten, North Rhine Westphalia · founded 1993 · 41 employees
$608.2Kraised
▾

Bitop develops bio-stabilizers for stabilizing nucleic acid, protein and cells against a variety of stress factors such as high temperatures, temperature fluctuations. In addition, it also manufactures cosmetic active ingredient, and bioactive compounds.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers — 2.1% of this cohort's audience
Activity: 1 product launches announced in 12 mo
Funding rounds
  • Jan 2018Grant (prize money)$608.2K
Founders & team
Daniel BergerCEO
Investors
Europa, b.value AG
Tech stack
Alpine.JsApple Icloud MailBootstrapBunnyConcrete CmsCookiefirst
#7
Funding Raised · Bonn, North Rhine Westphalia · founded 2002
$325.8Kraised
▾

LIFE & BRAIN provides research and development for the biomedical and neuroscientific technology platform. The company offers translational research for omics data interpreting diagnostic and therapeutic procedures. The company offers services for sequencing analyses using PacBio Sequel Technology, DNA Amplikonsequenzierung, de novo sequencing of genomes, re-sequencing of genomes, and Iso-Seq RNA sequencing.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 965 LinkedIn followers
Hiring: 1 hiring post in 12 mo (public) · hiring: Medical Technical Assistant (MTA), Biological Technical Assistant (BTA)
Funding rounds
  • Jan 2020Grant (prize money)—
  • Jan 2016Grant (prize money)$325.8K
  • Jan 2015Grant (prize money)—
  • Nov 2013Grant (prize money)—
Founders & team
Markus NothenCo-Founder & Co-CEOOliver BrustleCo-Founder & Co-CEOOtmar WiestlerCo-Founder
Investors
Europa
Tech stack
Apache Http ServerBootstrapIonosJqueryMysqlOpen Graph
#8
Acquired · Cologne, North Rhine Westphalia · founded 2010 · 27 employees
$109.8Kraised
▾

Sividon Diagnostics is a management buyout from Siemens Healthcare Diagnostics in Cologne. The company's main focus is in companion molecular diagnostics for personalized treatment of breast cancer. Sividon's EndoPredict is a second-generation, multigene prognostic test kit for patients diagnosed with breast cancer, detects the likelihood of metastases and helps guide treatment with chemotherapy as well as extended anti-hormone therapy. In Jan 2014, Myriad Genetics GmbH and Sividon Diagnostics GmbH announced that they have entered into an exclusive co-marketing agreement, covering the sales and marketing of Sividon's EndoPredict test outside of the United States

Funding rounds
  • Dec 2015Grant (prize money)$54.6K
  • Jul 2015Grant (prize money)$55.2K
  • Sep 2011Series A—
Founders & team
Christoph PetryFounder
Investors
EIC Fund, Kfw, Creathor Venture, Europa
#9
Seed · Cologne, North Rhine Westphalia
—raised
▾

Developer of a diagnostic device for the detection of pathogens. It offers a cartridge system that consists of DetechStamp and DetechChip for nucleic acid detection of infectious pathogens.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers
Activity: 1 product launches · 1 partnerships (incl. Clinical Virology Network (CVN)) announced in 12 mo
Founders & team
Robin BayerCTO and Co-FounderReza EsmaillieCo-Founder & CEO
Investors
neoteq ventures, NRW.Bank, Aquarius Investment Advisors, Meerkat, Campus Capital
#10
Public · Bielefeld, North Rhine Westphalia · founded 2000 · 31 employees
—raised
▾

PlasmidFactory is a contract manufacturer of Plasmid DNA for research, preclinical, clinical and commercial manufacturing purposes. They offer different grades of plasmids for research & preclinical studies (4 different grades) and commercial manufacturing purposes. Their High-Quality Grade plasmid DNA can be used in the GMP production of recombinant viruses, antibodies, induced pluripotent stem cells (iPS) and RNA used for clinical studies. The company claims that it can produce high-purity DNA, whose quality markedly exceeds that of kit-based systems, due to their unique capillary gel electrophoresis (CGE) technology which allows determination and quantification of the proportion of the ccc (covalently closed circular) form, which is the most reliable active conformation. They also offer specialised plasmids such as Helper Packaging Plasmids (for Adeno Associated Virus production), reporter genes, minicircle DNA(with only the gene of interest and its regulating sequence motifs).

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers
Activity: 1 product launches · 1 partnerships (incl. Fraunhofer IZI) announced in 12 mo
Funding rounds
  • Sep 2022PE—
Investors
ARCHIMED
Tech stack
Apache Http ServerCloudflareCloudflare Bot ManagementCookiebotCore-JsGoogle Analytics
#11
Series B · Duisburg, North Rhine Westphalia · founded 2016 · 47 employees
—raised
▾

Developer of cell-free molecular assays. The company has developed a proprietary technology that identifies pathogens via next-generation sequencing of cell-free nucleic acids in patients' plasma samples. It detects bacteria, fungi, viruses, and parasites.

Funding rounds
  • May 2022Series B—
  • Mar 2020Series A—
  • Dec 2017Seed—
Founders & team
Philip StevensCo-Founder & CEOPeter HaugFounding Angel and Co-Founder
Investors
Tech Tour, HTGF, Earlybird, Wieland Capital, SquareOne, Revent
Tech stack
Amazon SesAmazon Web ServicesApple Icloud MailGoogle WorkspaceHstsMatomo Analytics
#12
Deadpooled · Dusseldorf, North Rhine Westphalia · founded 2011
—raised
▾

Epivios develops epigenetics-based molecular diagnostic tests for cancer. Its proprietary epigenetic platform enables the comparison of samples with dissimilar genetic constitutions with great accuracy. First application is for the early diagnosis of bladder cancer and prostate cancer. Current status of the company is unknown.

Funding rounds
  • Jul 2012Seed—
Founders & team
Nicole GrothCEO & MD
Investors
HTGF, Life Science Incubator

Funding & investor landscape

$150.9Mtotal disclosed funding
8companies funded
34disclosed rounds
0rounds last 90 days
Most active investors
Europa6 rounds
HTGF4 rounds
Creathor Venture3 rounds
Kfw3 rounds
NRW.Bank3 rounds
Earlybird2 rounds
ARCHIMED1 rounds
Aquarius Investment Advisors1 rounds
Arch Venture Partners1 rounds
Ayoxxa Biosystems1 rounds

Notable founders

Jing Zhou
Co-Founder · Singleron
Nan Fang
Co-Founder & CEO · Singleron
Stefan Miltenyi
Founder & MD · Miltenyi Biotec
Norbert Hentschel
CFO / Managing Director · Miltenyi Biotec
Daniel Berger
CEO · Bitop
Markus Nothen
Co-Founder & Co-CEO · LIFE & BRAIN
Oliver Brustle
Co-Founder & Co-CEO · LIFE & BRAIN
Christoph Petry
Founder · Sividon
Robin Bayer
CTO and Co-Founder · Detechgene
Reza Esmaillie
Co-Founder & CEO · Detechgene
Philip Stevens
Co-Founder & CEO · Noscendo
Peter Haug
Founding Angel and Co-Founder · Noscendo
Prism market signals · Germany · country-scoped Prism corpus, 2,090,129 docs

Market landscape — 10 sub-themes by coverage

Share of Genomics coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

Common questions

How many Genomics companies are there in North Rhine Westphalia, Germany?
Radar tracks 30 indexable Genomics companies headquartered in North Rhine Westphalia, Germany that meet our profile-completeness bar.
What is the total funding raised by Genomics companies in North Rhine Westphalia, Germany?
The Genomics companies in North Rhine Westphalia, Germany on this list have raised a combined $150.9M in disclosed equity funding across 8 funded companies.
Which is the highest-funded Genomics company in North Rhine Westphalia, Germany?
Singleron is the highest-funded Genomics company in North Rhine Westphalia, Germany, with $84.5M in disclosed equity funding.
How many Genomics companies in North Rhine Westphalia, Germany are funded?
8 of the 30 Genomics companies in North Rhine Westphalia, Germany on this list have disclosed at least one equity funding round.
How many Genomics unicorns are there in North Rhine Westphalia, Germany?
None of the Genomics companies in North Rhine Westphalia, Germany on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in North Rhine Westphalia, Germany Genomics companies?
The most active investors in North Rhine Westphalia, Germany Genomics companies on this list include Europa, HTGF, Creathor Venture, Kfw, NRW.Bank.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon